Alerts
4668 total results. Page 139 of 187.
Headlines that Matter for Companies and Executives in Regulated Industries
Colorado’s new consumer data protection law, the Protections for Consumer Data Privacy Act, took effect September 1 and companies now have another set of requirements to comply with for their data privacy compliance.
Monthly Wrap: News, insights and analysis from Arent Fox’s International Arbitration team.
Individuals with disabilities and their families have many options to set aside funds without jeopardizing eligibility for means-tested government benefits.
Retailers across the country are paying close attention to a series of legal battles over state laws that prohibit merchants from charging an extra fee to consumers who pay by credit card.
If the turbulence of 2018 caused business executives grief, the year ahead is unlikely to provide much relief. Foremost is the United States-Mexico-Canada Agreement (USMCA). If most political pundits are correct, the three governments will likely be able to ratify the USMCA in time to be in full fo
On October 11, the United States Patent and Trademark Office published a new final rule altering the claim construction standard applied in inter partes review, post grant review, and covered business method review proceedings.
The Department of Health and Human Services (HHS) has issued a proposed rule (PR) which would require any television advertisement for a drug or biological covered by Medicare or Medicaid to include a disclosure of the product’s “current list price” for a “typical” thirty day supply.
Headlines that Matter for Companies and Executives in Regulated Industries
On October 17, 2018, Canada celebrated Legalization Day – an event marking the end of a prohibition against recreational cannabis use.
Headlines that Matter for Companies and Executives in Regulated Industries
Efforts to update FDA’s personal care products regulations continue as Rep. Jan Schakowsky (D-IL) recently introduced H.R. 6903, the “Safe Cosmetics and Personal Care Products Act of 2018.”
President Trump is expected to sign into law a bill which will – among other things – expand the scope of the Open Payments reporting requirements mandated by Section 6002 of the Patient Protection and Affordable Care Act (often referred to as the Sunshine Act).
Headlines that Matter for Companies and Executives in Regulated Industries
On September 28, 2018, the Pharmaceutical Research and Manufacturers of America (PhRMA) filed an amended complaint to revive its lawsuit seeking to block implementation and enforcement of California’s drug price transparency law.
In December 2017, Congress passed major changes to the tax laws.
On October 1, 2018, the New York State Department of Labor announced its final regulations to prevent workplace harassment.
Headlines that Matter for Companies and Executives in Regulated Industries
In the last hour of the last day of last month, with 30 minutes to spare, US Trade Representative Lighthizer met the US self-imposed deadline and formally sent to Congress the agreed-upon text of a US-Mexico-Canada Agreement, or USMCA.
September Arbitration Wrap: News, Knowledge, and Insight
Last week, the Drug Enforcement Agency (DEA) published in the Federal Register its Final Order placing FDA-approved cannabidiol drug products (CBD) containing no more than 0.1 percent tetrahydrocannabinols in schedule V of the Controlled Substances Act.
US Customs and Border Protection’s Executive Assistant Commissioner of Field Operations, Todd Owen, recently spoke with Politico and confirmed that CBP will continue to apply long-standing US federal laws and regulations that treat marijuana as a banned substance at the US border.
Starting on January 1, 2020, fashion and retail companies from around the world will need to comply with the strongest online privacy law in the United States, the California Consumer Privacy Act of 2018.
The Trump Administration recently announced several major decisions, including: finalizing the List 3 products subject to additional duties and revealing its implementation schedule.
On September 11, 2018, hospital advocacy groups and three individual hospitals filed a complaint in the United States District Court for the District of Columbia.